What you should know:
1. Dr. Plevy will lead Synlogic’s research organization. He’ll report to Synlogic’s president and CEO.
2. A gastroenterologist, Dr. Plevy entered the commerce sector after an academic career.
3. Throughout his career, he served as lead investigator on several clinical trials and has published more than 100 referenced papers and articles.
4. Dr. Plevy succeeds Paul Miller, PhD, who joined Synlogic’s scientific advisory board.
5. On the position, Dr. Plevy said, “I am excited to join the company’s talented team to enable development of this novel class of living medicines with potential to provide new treatment options in a broad range of metabolic diseases, immune-mediated diseases and cancer.”
More articles on gastroenterology:
UK physician: US medical guidelines may be biased, overly aggressive
CRH Medical appoints Dr. Tushar Ramani CEO — 5 insights
5 insights into Allegheny Health Network’s new gastroenterology division head Dr. Elie Aoun
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
